Back to search

Article

Lentiviral vectors can be used for full-length dystrophin gene therapy

2017-03-17

Abstract excerpt

Abstract Duchenne Muscular Dystrophy (DMD) is caused by a lack of dystrophin expression in patient muscle fibres. Current DMD gene therapy strategies rely on the expression of internally deleted forms of dystrophin, missing important functional domains. Viral gene transfer of full-length dystrophin could restore wild-type functionality, although this approach is restricted by the limited capacity of recombinant vi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8febf444-a91f-5010-ac5c-5d9ee9873eba
DOI
10.1038/srep44775
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lentiviral vectors can be used for full-length dystrophin gene therapyDOI 10.1038/srep44775
Select a neighboring publication to make it the new centre.